VIGL
USDVigil Neuroscience Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$7.870
Haut
$7.880
Bas
$7.840
Volume
3.58M
Fondamentaux de l'Entreprise
Capitalisation Boursière
367.3M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
1.10M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LSEA, FARO, TASK, VIGL on Behalf of Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
VIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors to Contact the Firm
The law firm of Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Vigil Neuroscience, Inc. ...
Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
WATERTOWN, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, AXL, SWTX, VIGL on Behalf of Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Stifel Downgrades Vigil Neuroscience to Hold, Lowers Price Target to $8
Stifel analyst Paul Matteis downgrades Vigil Neuroscience from Buy to Hold and lowers the price target from $11 to $8.
HC Wainwright & Co. Downgrades Vigil Neuroscience to Neutral, Lowers Price Target to $8
HC Wainwright & Co. analyst Andrew Fein downgrades Vigil Neuroscience from Buy to Neutral and lowers the price target from $14 to $8.
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.